Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
4,224
Value
$71.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NTLA by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,224$71.5K<0.1%+3,641+624.5%AddedHolders
Q1 2026583$7.47K<0.1%+108+22.7%AddedHolders
Q4 2025475$4.27K<0.1%−1,490−75.8%ReducedHolders
Q3 20251,965$33.9K<0.1%−1,151−36.9%ReducedHolders
Q2 20253,116$29.2K<0.1%+1,055+51.2%AddedHolders
Q1 20252,061$14.7K<0.1%+416+25.3%AddedHolders
Q4 20241,645$19.2K<0.1%+890+117.9%AddedHolders
Q3 2024755$15.5K<0.1%−140−15.6%ReducedHolders
Q2 2024895$20.0K<0.1%−6,371−87.7%ReducedHolders
Q1 20247,266$199.9K<0.1%−1,610−18.1%ReducedHolders
Q4 20238,876$270.6K<0.1%+2,189+32.7%AddedHolders
Q3 20236,687$211.4K<0.1%−212−3.1%ReducedHolders
Q2 20236,899$281.3K<0.1%−151−2.1%ReducedHolders
Q1 20237,050$262.8K<0.1%+585+9.0%AddedHolders
Q4 20226,465$225.6K<0.1%−5,575−46.3%ReducedHolders
Q3 202212,040$673.0K<0.1%+3,345+38.5%AddedHolders
Q2 20228,695$449.0K<0.1%−6,508−42.8%ReducedHolders
Q1 202215,203$1.10M<0.1%+558+3.8%AddedHolders
Q4 202114,645$1.73M<0.1%+1,800+14.0%AddedHolders
Q3 202112,845$1.72M<0.1%+1,444+12.7%AddedHolders
Q2 202111,401$1.85M<0.1%+5,375+89.2%AddedHolders
Q1 20216,026$484.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.